Genomic heterogeneity in metastatic colorectal cancer (CRC) demonstrated by Copy Number Variation (CNV)

被引：0
|
作者：
Palmer, T. [1 ]
Wood, H. [1 ]
Taylor, M. [1 ]
Fateen, W. [1 ]
Chambers, P. [1 ]
Hindley, A. [1 ]
Carr, I. [1 ]
Quirke, P. [1 ]
机构：
[1] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-10-079
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [41] NGS-based 3D reconstruction reveals copy number changes as the major source of genomic heterogeneity in colorectal cancer
    Mamlouk, S.
    Childs, L.
    Oliveira, C.
    Daniel, H.
    Klauschen, F.
    Aust, D.
    Morkel, M.
    Wolf, T.
    Schaefer, R.
    Sers, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S6 - S6
  • [42] Patterns of copy number variation in cancer
    Greenman, C.
    EJC SUPPLEMENTS, 2008, 6 (09): : 117 - 117
  • [43] Array-based comparative genomic hybridization and copy number variation in cancer research
    Cho, E. K.
    Tchinda, J.
    Freeman, J. L.
    Chung, Y. -J.
    Cai, W. W.
    Lee, C.
    CYTOGENETIC AND GENOME RESEARCH, 2006, 115 (3-4) : 262 - 272
  • [44] Widespread Post-transcriptional Attenuation of Genomic Copy-Number Variation in Cancer
    Goncalves, Emanuel
    Fragoulis, Athanassios
    Garcia-Alonso, Luz
    Cramer, Thorsten
    Saez-Rodriguez, Julio
    Beltrao, Pedro
    CELL SYSTEMS, 2017, 5 (04) : 386 - +
  • [45] Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
    Jesper Andreas Palshof
    Estrid Vilma Solyom Høgdall
    Tim Svenstrup Poulsen
    Dorte Linnemann
    Benny Vittrup Jensen
    Per Pfeiffer
    Line Schmidt Tarpgaard
    Nils Brünner
    Jan Stenvang
    Mette Yilmaz
    Dorte Lisbet Nielsen
    BMC Cancer, 17
  • [46] Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
    Gambaro, Karen
    Marques, Maud
    McNamara, Suzan
    du Tertre, Mathilde Couetoux
    Diaz, Zuanel
    Hoffert, Cyrla
    Srivastava, Archana
    Hebert, Steven
    Samson, Benoit
    Lesperance, Bernard
    Ko, Yoo-Joung
    Dalfen, Richard
    St-Hilaire, Eve
    Sideris, Lucas
    Couture, Felix
    Burkes, Ronald
    Harb, Mohammed
    Camlioglu, Errol
    Gologan, Adrian
    Pelsser, Vincent
    Constantin, Andre
    Greenwood, Celia M. T.
    Tejpar, Sabine
    Kavan, Petr
    Kleinman, Claudia L.
    Batist, Gerald
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (04):
  • [47] Landscape of MET genomic alterations in colorectal cancer (CRC).
    Yasin, Faiza
    Pavlick, Dean
    Ross, Jeffrey S.
    Cecchini, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 247 - 247
  • [48] Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
    Palshof, Jesper Andreas
    Hogdall, Estrid Vilma Solyom
    Poulsen, Tim Svenstrup
    Linnemann, Dorte
    Jensen, Benny Vittrup
    Pfeiffer, Per
    Tarpgaard, Line Schmidt
    Brunner, Nils
    Stenvang, Jan
    Yilmaz, Mette
    Nielsen, Dorte Lisbet
    BMC CANCER, 2017, 17
  • [49] Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework
    Pataky, Reka E.
    Peacock, Stuart
    Bryan, Stirling
    Sadatsafavi, Mohsen
    Regier, Dean A.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024,
  • [50] Tumor genomic profiling (TGP) in metastatic colorectal cancer (CRC): Bridging the community and the tertiary cancer center through genomic consultation (GC).
    Kaczmar, John M.
    Gustafson, Karen S.
    Wong, Yu Ning
    Minniti, Carl J.
    Sandilya, Vijay Krishna
    Sprandio, John David
    Chertock, Yana
    Hart, Caitlin
    Hall, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345